• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Anavex Lf SC (NQ: AVXL )

    6.818 +0.198 (+2.99%)
    Streaming Delayed Price Updated: 9:45 AM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Anavex Lf SC

    < Previous 1 2 3 4 5 6 7 8 Next >
    21 Stocks Moving in Monday's Pre-Market Session
    Gainers Creatd Inc (NASDAQ: CRTD) shares rose 33.9% to $4.27 in pre-market trading after dropping around 9% on Friday. Oxbridge Re Holdings Ltd (NASDAQ: OXBR) shares rose 13.2%... 
    Via Benzinga
    Biogen Stock Drags On Alzheimer's Players As FDA Requests Review Of Aduhelm Approval
    Biogen stock tumbled Friday after the FDA requested an independent review of the process that led to its recent Alzheimer's approval. 
    Via Investor's Business Daily
    Exposures Product Safety
    Cramer Shares His Thoughts On Anavex Life Sciences, Upstart And More
    On CNBC's "Mad Money Lightning Round," Jim Cramer said he is intrigued about Anavex Life Sciences Corp (NASDAQ: AVXL) because Biogen Inc (NASDAQ: BIIB) data doesn... 
    Via Benzinga
    Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
    Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) advancing about 8% year-to-date ... 
    Via Benzinga
    58 Biggest Movers From Yesterday
    Gainers BSQUARE Corporation (NASDAQ: BSQR) shares jumped 206.9% to close at $8.04 on Tuesday on abnormally-high volume possibly amid increased attention from retail investors.... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock moved upwards by 93.55% to $24.33 during Tuesday's regular session. As of 12:30 EST, this security is trading at... 
    Via Benzinga
    35 Stocks Moving In Tuesday's Mid-Day Session
    Gainers Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) shares jumped 111.5% to $26.58 after the company announced positive results from its Phase 1b clinical trial of CVL-231... 
    Via Benzinga
    Why This Anavex Life Sciences Analyst Is Lifting Their Price Target
    A Cantor Fitzgerald analyst is incrementally bullish on shares of Anavex Life Sciences, Corp (NASDAQ: 
    Via Benzinga
    Anavex Life Sciences Stock Rallies: Technical Levels To Watch
    Anavex Life Sciences Corp. (NASDAQ: AVXL) shares traded higher Monday after the company announced ANAVEX2-73, the company’s main pipeline drug, improved both primary... 
    Via Benzinga
    Why Anavex Life Sciences Shares Are Up 17% Today
    The biopharma developer dropped some big (but mostly expected) news about the success of one of its drugs. 
    Via The Motley Fool
    Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027
    Via FinancialNewsMedia
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers Intellia Therapeutics (NASDAQ:NTLA 
    Via Benzinga
    44 Stocks Moving In Monday's Mid-Day Session
    Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software... 
    Via Benzinga
    The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,... 
    Via Benzinga
    Anavex Life Sciences Stock Jumps As Blarcamesine Shows Convincing Biomarker-Correlating Efficacy Data In Parkinson's Disease Dementia Patients
    Anavex Life Sciences Corp (NASDAQ: AVXL) has reported that SIGMAR1 mRNA expression correlates positively with responses in efficacy endpoints in the Phase 2 trial... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 62.0% to $143.91 during Monday's pre-market session. The company's market cap stands at $9.8 billion.... 
    Via Benzinga
    60 Biggest Movers From Yesterday
    Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its... 
    Via Benzinga
    3 Top Biotech Stocks to Buy Right Now
    These three biotech stocks recently had positive news coming out of phase 2 trials, making them good choices for growth-oriented investors. 
    Via The Motley Fool
    Alzheimer’s Treatment Market Is Anticipated To Reach $2 Billion By The End Of 2027
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume... 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Gainers vTv Therapeutics (NASDAQ:VTVT) shares rose 30.08% to $3.07 during Tuesday's pre-market session. The company's market cap stands at $251.7 million. Adial... 
    Via Benzinga
    The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
    Via Benzinga
    48 Biggest Movers From Yesterday
    Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,... 
    Via Benzinga
    Why Anavex Life Sciences Blasted Higher Today
    The good news keeps coming for one of the biotech's pipeline drugs. 
    Via The Motley Fool
    10 Health Care Stocks Showing Unusual Options Activity In Today's Session
    This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a... 
    Via Benzinga
    31 Stocks Moving In Monday's Mid-Day Session
    Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)... 
    Via Benzinga
    How Anavex Extended Its 5-Week Rally On Promising Results In Rett Syndrome
    Anavex Life Sciences surged Monday on a positive study in Rett Syndrome, helping AVXL stock extend a triple-digit gain over a five-week rally. 
    Via Investor's Business Daily
    Anavex Life's Rett Syndrome Candidate Shows Promising Biomarker Correlating Efficacy Data
    Anavex Life Sciences Corp (NASDAQ: AVXL) has reported a predictive biomarker response from its Phase 2 trial of ANAVEX2-73 (blarcamesine) in adult female patients with... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Gainers MediciNova (NASDAQ:MNOV) shares moved upwards by 50.79% to $5.67 during Monday's pre-market session. The market value of their outstanding shares is at $276.5... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.